Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review

Area of Science:

• Oncology
• Natural Products Chemistry
• Molecular Biology

Background:

• Naturally derived compounds are increasingly recognized for their potential in cancer prevention and treatment.
• Sulforaphane (SFN), an isothiocyanate from cruciferous vegetables, demonstrates significant chemosensitizing properties against various cancer types.
• Chemoresistance is a major challenge in cancer therapy, necessitating novel strategies to enhance treatment efficacy.

Purpose of the Study:

• To review the multifaceted role of sulforaphane (SFN) in oncology.
• To elucidate the mechanisms by which SFN enhances cancer cell sensitivity to chemotherapy.
• To highlight the potential of SFN as an adjunct therapy for augmenting conventional cancer treatments.

Main Methods:

• Review of preclinical and clinical investigations on SFN in cancer.
• Analysis of SFN's effects on cellular signaling pathways (e.g., Akt/mTOR, NF-κB).
• Examination of SFN's influence on key cancer-related genes and proteins (e.g., p53, Bcl-2).

Main Results:

• SFN modulates critical signaling pathways and regulates key proteins involved in cell survival and apoptosis.
• SFN synergistically inhibits cancer cell proliferation, invasion, migration, and metastasis when combined with chemotherapeutic agents.
• SFN potentiates drug-induced apoptosis, counteracting chemoresistance.

Conclusions:

• Sulforaphane (SFN) exhibits potent chemosensitizing capabilities, enhancing the efficacy of conventional chemotherapy.
• SFN's ability to modulate signaling pathways and key molecules positions it as a promising adjunct in cancer therapy.
• Further research into SFN is warranted to fully explore its therapeutic potential in cancer management.